Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
Revenue
Abbott India Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
Revenue
₹53.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Revenue
₹272.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Revenue
₹253.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Revenue
₹474.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Revenue
₹186.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Revenue
₹104.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
See Also
What is Abbott India Ltd's Revenue?
Revenue
53.5B
INR
Based on the financial report for Mar 31, 2023, Abbott India Ltd's Revenue amounts to 53.5B INR.
What is Abbott India Ltd's Revenue growth rate?
Revenue CAGR 5Y
10%
Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for Abbott India Ltd have been 9% over the past three years , 10% over the past five years .